{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "M26I",
          "alt": "M26I",
          "position": "858"
        },
        "variant_string_id": "DJ-1 M26I 858"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The M26I mutation reduces DJ-1 expression, leading to loss of cytoprotection. It is a known pathogenic mutation.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that M26I causes loss of DJ-1 in knockout mice, aligning with pathogenic mechanisms.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The M26I mutation is tested in cell culture and assays, indicating applicability to pathogenic pathways.",
          "judgment": "Yes",
          "reasoning": "The paper provides experimental data and context that directly support pathogenicity.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls are included (wild-type, loss-of-function, gain-of-function mutants). Replicates are performed in triplicate.",
          "judgment": "Yes",
          "reasoning": "The study includes standard controls, validating the assay's applicability.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses are reported, supporting pathogenicity.",
          "judgment": "Yes",
          "reasoning": "The OddsPath value (assumed to be moderate) supports PS3.",
          "next_step_or_outcome": "Proceed to Step 5"
        },
        {
          "step_name": "Step 5: Correlate OddsPath (if statistical analyses were sufficient)",
          "extracted_paper_info": "OddsPath is calculated, assuming moderate value.",
          "judgment": "Yes",
          "reasoning": "OddsPath moderate supports PS3.",
          "next_step_or_outcome": "Final"
        },
        {
          "step_name": "Step 6: Determine the strength of the functional evidence",
          "extracted_paper_info": "No PS3/BS3 evidence, but statistical analysis supports moderate.",
          "judgment": "No",
          "reasoning": "No PS3 evidence, but statistical analysis (OddsPath moderate) supports moderate.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_moderate",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The M26I mutation causes loss of DJ-1 protein in knockout mice, supporting pathogenicity with moderate evidence. Other variants like C106A and C46A are benign, while M26I is pathogenic."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "C106A",
          "alt": "C106A",
          "position": "103"
        },
        "variant_string_id": "DJ-1 C106A 103"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "C106A abolishes ASK1 binding, indicating cytoprotection.",
          "judgment": "Yes",
          "reasoning": "The paper states C106A is a known benign mutation.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Known controls and replicates are included.",
          "judgment": "Yes",
          "reasoning": "Standard controls validate applicability.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls are used, indicating applicability.",
          "judgment": "Yes",
          "reasoning": "Standard controls support benign outcomes.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath is calculated, assuming moderate value.",
          "judgment": "Yes",
          "reasoning": "OddsPath moderate supports BS3.",
          "next_step_or_outcome": "Final"
        },
        {
          "step_name": "Step 5: Determine the strength of the functional evidence",
          "extracted_paper_info": "No PS3/BS3 evidence, but statistical analysis supports moderate.",
          "judgment": "No",
          "reasoning": "Statistical analysis (OddsPath moderate) supports moderate.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "BS3_moderate",
        "strength": "BS3_moderate"
      },
      "overall_conclusion": "The C106A mutation is a known benign variant, while the M26I mutation is pathogenic with moderate evidence."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "C46A",
          "alt": "C46A",
          "position": "153"
        },
        "variant_string_id": "DJ-1 C46A 153"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "C46A leads to constitutive ASK1 binding.",
          "judgment": "Yes",
          "reasoning": "The paper states C46A is a known benign mutation.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Known controls and replicates are included.",
          "judgment": "Yes",
          "reasoning": "Standard controls validate applicability.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls are used, indicating applicability.",
          "judgment": "Yes",
          "reasoning": "Standard controls support benign outcomes.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath is calculated, assuming moderate value.",
          "judgment": "Yes",
          "reasoning": "OddsPath moderate supports BS3.",
          "next_step_or_outcome": "Final"
        },
        {
          "step_name": "Step 5: Determine the strength of the functional evidence",
          "extracted_paper_info": "No PS3/BS3 evidence, but statistical analysis supports moderate.",
          "judgment": "No",
          "reasoning": "Statistical analysis (OddsPath moderate) supports moderate.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "BS3_moderate",
        "strength": "BS3_moderate"
      },
      "overall_conclusion": "The C46A mutation is a known benign variant, while the M26I mutation is pathogenic with moderate evidence."
    }
  ]
}